Benign lipomatous neoplasm of skin and subcutaneous tissue of other sites, commonly referred to as a lipoma, is a slow-growing, mesenchymal tumor composed of mature adipocytes (fat cells). These lesions are benign and typically present as soft, mobile, subcutaneous masses. The specific code D17.39 identifies these neoplasms in cutaneous and subcutaneous locations that are not categorized under the head, face, neck, trunk, or limbs, or where the specific anatomical site is documented but not separately indexed. While most lipomas are solitary, multiple occurrences may be observed in conditions like familial multiple lipomatosis. They are typically well-circumscribed by a thin fibrous capsule and do not demonstrate invasive growth. While generally asymptomatic and requiring only observation, they may be surgically removed for cosmetic reasons or if they cause functional impairment by compressing adjacent neurovascular structures.
Distinguish between skin/subcutaneous and deep soft tissue origin.
Example: The patient presents with a 4 cm, soft, mobile, non-tender subcutaneous mass located in the left axilla. The mass is distinct from the underlying fascia and deep musculature, characteristic of a benign lipomatous neoplasm of skin and subcutaneous tissue of other sites (D17.39). No associated lymphadenopathy is noted in the axillary tail. Patient is currently stable with no systemic symptoms, but requests excision due to mechanical irritation from clothing.
Billing Focus: Documentation of anatomical depth as subcutaneous rather than intramuscular or subfascial to support 11400-11446 series vs 20000 series CPT codes.
Document the presence of symptoms like pain or compression to support medical necessity for excision.
Example: Clinical evaluation of the subcutaneous mass on the right groin reveals a 3 cm lobulated lipoma. The patient reports sharp, localized pain upon hip flexion, suggesting possible nerve compression or angiolipoma variant. Assessment: Benign lipomatous neoplasm of skin and subcutaneous tissue of other sites (D17.39). Procedure: Planned excision to alleviate functional impairment and pain. Comorbidities include Type 2 Diabetes (E11.9) which may affect wound healing.
Billing Focus: Detailed symptom reporting (pain, functional impairment) justifies the medical necessity of surgical intervention for benign lesions.
Specify the exact anatomical site when it falls outside standard categories like face, trunk, or limbs.
Example: Patient noted a slow-growing, 5 cm soft tissue mass in the perineal region. Physical exam confirms a soft, well-circumscribed subcutaneous lipomatous lesion. Documentation: Benign lipomatous neoplasm of skin and subcutaneous tissue of other sites (D17.39), specifically the perineum. Lesion is currently asymptomatic and will be monitored for changes.
Billing Focus: Using the 'other sites' code D17.39 requires clear anatomical description in the note to differentiate it from trunk (D17.1) or limb (D17.2) codes.
Describe the clinical appearance and morphology to rule out malignant mimics like liposarcoma.
Example: Examination of a 6 cm subcutaneous mass in the left inguinal fold. The lesion is soft, homogenous, and has well-defined borders with no fixation to skin or deeper structures. Morphology is highly suggestive of a benign lipomatous neoplasm (D17.39). Due to size greater than 5 cm, a referral for ultrasound is initiated to confirm benign features and absence of vascularity before excision.
Billing Focus: Documentation of size and morphology supports the complexity of the diagnostic evaluation and potential surgical approach.
Include relevant comorbidities and their impact on management or surgical risk.
Example: Patient with a benign lipomatous neoplasm of the subcutaneous tissue of the right axilla (D17.39). Management plan: Surgical excision is deferred at this time due to the patient's current treatment for morbid obesity (E66.01) and poorly controlled hypertension (I10), which increase perioperative risk for a non-urgent benign lesion.
Billing Focus: Comorbidities documented in relation to the treatment plan for the lipoma support higher complexity levels for E/M services.
Common surgical procedure for removing symptomatic lipomas from the groin or axilla (trunk/extremity margin areas).
Applied for larger lipomas in the 'other' site categories like the axillary tail.
Standard code for an established patient presenting for monitoring or initial evaluation of a slow-growing, asymptomatic lipoma.
Used when a new patient presents specifically for the evaluation of a newly discovered subcutaneous mass.
Used for symptomatic lipomas where surgical planning and risk assessment (e.g., anticoagulation management) are involved.
Frequently ordered to confirm the lipomatous nature of a mass and check for vascularity.
Used in conjunction with excision codes when the lipoma removal requires layered tissue repair.
Necessary to confirm the benign lipomatous nature of the tissue after surgical removal.
Often performed when a lipoma is misdiagnosed as an infected cyst or abscess before definitive identification.
Used if the clinician is unsure of the diagnosis and wants to sample the overlying skin or superficial portion of the mass.